RELATING CAROTID PLAQUE VOLUME REDUCTION ASSESSED BY 3T MRI WITH INFLAMMATORY CYTOKINE CHANGE FOLLOWING 6 MONTH STATIN TREATMENT  by Migrino, Raymond Q. et al.
A158.E1477
JACC Maarch 9, 2010
Volume 55, issue 10A
 VASCULAR DISEASE
RELATING CAROTID PLAQUE VOLUME REDUCTION ASSESSED BY 3T MRI WITH INFLAMMATORY 
CYTOKINE CHANGE FOLLOWING 6 MONTH STATIN TREATMENT
ACC Poster Contributions
Georgia World Congress Center, Hall B5
Sunday, March 14, 2010, 9:30 a.m.-10:30 a.m.
Session Title: Peripheral Arterial/Carotid Disease/Aortic Disease
Abstract Category: Peripheral Arterial/Carotid Disease/Aortic Disease
Presentation Number: 1057-359
Authors: Raymond Q. Migrino, Leanne Harmann, Robert Prost, Mark Bowers, Medical College of Wisconsin, Milwaukee, WI
Background: The beneficial effects of statins in plaque regression/stabilization arise from both lipid lowering and systemic antiinflammatory 
effects. The relationship between change in inflammatory cytokines (IC) and in-vivo change in plaque burden is not well established. Our aim is to 
measure change in IC following 6 months of statin treatment in patients with carotid atherosclerosis and relate these to change in plaque volume 
(PV) and plaque component as measured by 3T MRI.
Methods: 19 subjects (14 males, 67±11 years) with carotid atherosclerosis had carotid MRI at baseline and following 6 months of statin 
treatment. Sera was drawn at both time points and analyzed for 18 inflammatory cytokines (Bioplex cytokine assay kit) and compared. Plaque 
volume and plaque component volume were measured using Plaqueview software from T1, T2, proton density and time of flight 3T MRI images (±12 
mm from flow divider, 0.6x0.6x2mm spatial resolution) and correlated with change in cytokine levels.
Results: Carotid PV had significant correlation with hsCRP, interleukin (IL)-6 and IL-17 (R=0.43, 0.36 and 0.73, all p<0.05). Following 6 month statin 
treatment, PV decreased 7.8% (1123±72 vs. 1035±33 mm3, p=0.015) while volume of necrotic component changed from 188±26 to 173±32 mm3 
(p=NS) . There was significant reduction in IL-1β (13.9±8 vs. 0.6±0.1 pg/mLp<0.001), IL-7 (10.6±3 vs. 6.9±0.7 pg/mL, p=0.03) and IL-9 (50±25 vs. 
16±6 pg/mL, p=0.045). LDL changed from 92±8 to 78±6 mg/dL while hsCRP changed from 2.6±0.7 to 1.8±0.4 mg/L (both p=NS). Among cytokines, 
only reduction of IL-7 was associated with reduction in plaque necrotic volume (R=0.47, p=0.04; R=0.44, p=0.05 vs. change in PV).
Conclusions: In patients with carotid atherosclerosis, 6 month statin treatment is associated with plaque volume reduction as measured by 
3T MRI, as well as reduction in IL-1β, IL-7 and IL-9. Among 18 cytokines tested only IL-7, a cytokine previously associated with clinical plaque 
vulnerability, correlated with change in carotid plaque necrotic volume. This initial result may lead to studies to determine the clinical utility of this 
systemic marker in serial assessment of plaque vulnerability and response to treatment.
